Comment on “Duration of rifampin therapy is a key determinant of improved outcomes in early-onset acute prosthetic joint infection due to Staphylococcus treated with a debridement, antibiotics and implant retention (DAIR): a retrospective multicenter study in France” by Becker et al. (2020)

Detalles Bibliográficos
Autores principales: Scheper, Henk, de Boer, Mark G. J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Copernicus GmbH 2020
Materias:
Letter
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7517664/
https://www.ncbi.nlm.nih.gov/pubmed/32983843
http://dx.doi.org/10.5194/jbji-6-17-2020
_version_ 1783587269543723008
author Scheper, Henk
de Boer, Mark G. J.
author_facet Scheper, Henk
de Boer, Mark G. J.
author_sort Scheper, Henk
collection PubMed
description
format Online
Article
Text
id pubmed-7517664
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Copernicus GmbH
record_format MEDLINE/PubMed
spelling pubmed-75176642020-09-25 Comment on “Duration of rifampin therapy is a key determinant of improved outcomes in early-onset acute prosthetic joint infection due to Staphylococcus treated with a debridement, antibiotics and implant retention (DAIR): a retrospective multicenter study in France” by Becker et al. (2020) Scheper, Henk de Boer, Mark G. J. J Bone Jt Infect Letter Copernicus GmbH 2020-07-22 /pmc/articles/PMC7517664/ /pubmed/32983843 http://dx.doi.org/10.5194/jbji-6-17-2020 Text en Copyright: © 2020 Henk Scheper and Mark G. J. de Boer This work is licensed under the Creative Commons Attribution 4.0 International License. To view a copy of this licence, visit https://creativecommons.org/licenses/by/4.0/
spellingShingle Letter
Scheper, Henk
de Boer, Mark G. J.
Comment on “Duration of rifampin therapy is a key determinant of improved outcomes in early-onset acute prosthetic joint infection due to Staphylococcus treated with a debridement, antibiotics and implant retention (DAIR): a retrospective multicenter study in France” by Becker et al. (2020)
title Comment on “Duration of rifampin therapy is a key determinant of improved outcomes in early-onset acute prosthetic joint infection due to Staphylococcus treated with a debridement, antibiotics and implant retention (DAIR): a retrospective multicenter study in France” by Becker et al. (2020)
title_full Comment on “Duration of rifampin therapy is a key determinant of improved outcomes in early-onset acute prosthetic joint infection due to Staphylococcus treated with a debridement, antibiotics and implant retention (DAIR): a retrospective multicenter study in France” by Becker et al. (2020)
title_fullStr Comment on “Duration of rifampin therapy is a key determinant of improved outcomes in early-onset acute prosthetic joint infection due to Staphylococcus treated with a debridement, antibiotics and implant retention (DAIR): a retrospective multicenter study in France” by Becker et al. (2020)
title_full_unstemmed Comment on “Duration of rifampin therapy is a key determinant of improved outcomes in early-onset acute prosthetic joint infection due to Staphylococcus treated with a debridement, antibiotics and implant retention (DAIR): a retrospective multicenter study in France” by Becker et al. (2020)
title_short Comment on “Duration of rifampin therapy is a key determinant of improved outcomes in early-onset acute prosthetic joint infection due to Staphylococcus treated with a debridement, antibiotics and implant retention (DAIR): a retrospective multicenter study in France” by Becker et al. (2020)
title_sort comment on “duration of rifampin therapy is a key determinant of improved outcomes in early-onset acute prosthetic joint infection due to staphylococcus treated with a debridement, antibiotics and implant retention (dair): a retrospective multicenter study in france” by becker et al. (2020)
topic Letter
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7517664/
https://www.ncbi.nlm.nih.gov/pubmed/32983843
http://dx.doi.org/10.5194/jbji-6-17-2020
work_keys_str_mv AT scheperhenk commentondurationofrifampintherapyisakeydeterminantofimprovedoutcomesinearlyonsetacuteprostheticjointinfectionduetostaphylococcustreatedwithadebridementantibioticsandimplantretentiondairaretrospectivemulticenterstudyinfrancebybeckeretal2020
AT deboermarkgj commentondurationofrifampintherapyisakeydeterminantofimprovedoutcomesinearlyonsetacuteprostheticjointinfectionduetostaphylococcustreatedwithadebridementantibioticsandimplantretentiondairaretrospectivemulticenterstudyinfrancebybeckeretal2020

Ejemplares similares